Epidemiology of human papillomavirus infection

被引:39
作者
Dillner, J
Meijer, CJLW
von Krogh, G
Horenblas, S
机构
[1] Karolinska Inst, Ctr Microbiol & Tumor Biol, SE-17177 Stockholm, Sweden
[2] Free Univ Amsterdam, Dept Pathol, Amsterdam, Netherlands
[3] Netherlands Canc Inst, Antoni Van Leeuwenhoek Hosp, Amsterdam, Netherlands
[4] Karolinska Hosp, Dept Dermatol, S-10401 Stockholm, Sweden
来源
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY | 2000年 / 34卷
关键词
epidemiology; etiology; human papillomaviurs; penis; squamous cell carcinoma;
D O I
10.1080/00365590050509922
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Anogenital human papillomavirus (HPV) infection is a sexually transmitted disease (STD) that typically follows a self-limiting transient course for both sexes. The HPV incidences and prevalences vary greatly, because they reflect the sexual activity of the individuals studied and of the population they are in contact with. Higher prevalences are seen in young, sexually active groups and in high-risk areas for cervical and penile cancer, e.g. in Colombia. There has also been an increasing trend with time in Western Europe, paralleling the spread of other STDs and changes in sexual behavior. Penile intraepithelial neoplasia is usually positive for high-risk HPV DNA, mostly of type 16, whereas only approximate to 50% of invasive penile cancers are positive for HPV DNA. This is similar to the role of high-risk HPV in vulvar carcinoma, where the attributable proportion is also approximate to 40-50%. Moreover, in both sites similar histologic types of squamous cell carcinoma, i.e. the basoloid and basaloid/warty types, an mainly associated with high-risk HPV types. The studies performed so far have indicated that HPV has an etiological role in penile cancer, although the attributable proportion may be only approximate to 40-50%.
引用
收藏
页码:194 / 200
页数:7
相关论文
共 84 条
[31]  
FLEISCH PM, 1996, J UROLOGY, V155, P2035
[32]   PREFERENTIAL ASSOCIATION OF HUMAN PAPILLOMAVIRUS WITH HIGH-GRADE HISTOLOGIC VARIANTS OF PENILE-INVASIVE SQUAMOUS-CELL CARCINOMA [J].
GREGOIRE, L ;
CUBILLA, AL ;
REUTER, VE ;
HAAS, GP ;
LANCASTER, WD .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (22) :1705-1709
[33]  
Griffiths TRL, 1999, BJU INT, V84, P579
[34]  
GRUIJL TD, 1997, JNCI-J NATL CANCER I, V89, P630
[35]  
GRUSSENDORFCONEN EI, 1986, LANCET, V2, P1092
[36]   PERSISTENCE OF TYPE-SPECIFIC HUMAN PAPILLOMAVIRUS INFECTION AMONG CYTOLOGICALLY NORMAL WOMEN [J].
HILDESHEIM, A ;
SCHIFFMAN, MH ;
GRAVITT, PE ;
GLASS, AG ;
GREER, CE ;
ZHANG, T ;
SCOTT, DR ;
RUSH, BB ;
LAWLER, P ;
SHERMAN, ME ;
KURMAN, RJ ;
MANES, MM .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02) :235-240
[37]   DETERMINANTS OF GENITAL HUMAN PAPILLOMAVIRUS INFECTION IN LOW-INCOME WOMEN IN WASHINGTON, DC [J].
HILDESHEIM, A ;
GRAVITT, P ;
SCHIFFMAN, MH ;
KURMAN, RJ ;
BARNES, W ;
JONES, S ;
TCHABO, JG ;
BRINTON, LA ;
COPELAND, C ;
EPP, J ;
MANOS, MM .
SEXUALLY TRANSMITTED DISEASES, 1993, 20 (05) :279-285
[38]   PREVALENCE AND RISK-FACTORS OF GENITAL HUMAN PAPILLOMAVIRUS (HPV) INFECTIONS IN HEALTHY-MALES - A STUDY ON FINNISH CONSCRIPTS [J].
HIPPELAINEN, M ;
SYRJANEN, S ;
HIPPELAINEN, M ;
KOSKELA, H ;
PULKKINEN, J ;
SAARIKOSKI, S ;
SYRJANEN, K .
SEXUALLY TRANSMITTED DISEASES, 1993, 20 (06) :321-328
[39]   Natural history of cervicovaginal papillomavirus infection in young women [J].
Ho, GYF ;
Bierman, R ;
Beardsley, L ;
Chang, CJ ;
Burk, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (07) :423-428
[40]   Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison [J].
Jacobs, MV ;
Snijders, PJF ;
Voorhorst, FJ ;
Dillner, J ;
Forslund, O ;
Johansson, B ;
Doeberitz, MVK ;
Meijer, CJLM ;
Meyer, T ;
Nindl, I ;
Pfister, H ;
Stockfleth, E ;
Strand, A ;
Wadell, G ;
Walboomers, JMM .
JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (07) :498-503